Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 2
2018 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

4 results
Results by year
Filters applied: . Clear all
Page 1
[Update on anti-N-methyl-D-aspartate receptor encephalitis].
Kovac S, Alferink J, Ahmetspahic D, Arolt V, Melzer N. Kovac S, et al. Among authors: ahmetspahic d. Nervenarzt. 2018 Jan;89(1):99-112. doi: 10.1007/s00115-017-0405-0. Nervenarzt. 2018. PMID: 28932896 Review. German.
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Gross CC, Ahmetspahic D, Ruck T, Schulte-Mecklenbeck A, Schwarte K, Jörgens S, Scheu S, Windhagen S, Graefe B, Melzer N, Klotz L, Arolt V, Wiendl H, Meuth SG, Alferink J. Gross CC, et al. Among authors: ahmetspahic d. Neurol Neuroimmunol Neuroinflamm. 2016 Oct 12;3(6):e289. doi: 10.1212/NXI.0000000000000289. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27766281 Free PMC article.
Interaction between childhood maltreatment on immunogenetic risk in depression: Discovery and replication in clinical case-control samples.
Cohen-Woods S, Fisher HL, Ahmetspahic D, Douroudis K, Stacey D, Hosang GM, Korszun A, Owen M, Craddock N, Arolt V, Dannlowski U, Breen G, Craig IW, Farmer A, Baune BT, Lewis CM, Uher R, McGuffin P. Cohen-Woods S, et al. Among authors: ahmetspahic d. Brain Behav Immun. 2018 Jan;67:203-210. doi: 10.1016/j.bbi.2017.08.023. Epub 2017 Sep 1. Brain Behav Immun. 2018. PMID: 28867280
Altered B Cell Homeostasis in Patients with Major Depressive Disorder and Normalization of CD5 Surface Expression on Regulatory B Cells in Treatment Responders.
Ahmetspahic D, Schwarte K, Ambrée O, Bürger C, Falcone V, Seiler K, Kooybaran MR, Grosse L, Roos F, Scheffer J, Jörgens S, Koelkebeck K, Dannlowski U, Arolt V, Scheu S, Alferink J. Ahmetspahic D, et al. J Neuroimmune Pharmacol. 2018 Mar;13(1):90-99. doi: 10.1007/s11481-017-9763-4. Epub 2017 Sep 13. J Neuroimmune Pharmacol. 2018. PMID: 28905187